Every result, read before it lands. Judged after.
Sign in
NIFTY 50 22,776.10 +0.98% NIFTY BANK 55,128.40 +0.76% NIFTY IT 28,136.05 -0.59% NIFTY MIDCAP 100 59,761.20 +1.08% NIFTY SMALLCAP 100 19,448.70 +1.56% NIFTY AUTO 25,541.95 +0.47% NIFTY PHARMA 26,549.60 +1.66% NIFTY FMCG 45,205.35 +1.40%
Closed Close 6 Oct

All results · NIFTY HEALTHCARE INDEX

Every judged result on record. Open a company to see its every judged result.

448results judged 18read right 34read wrong 49flat / no call 347unread
38%beat the market
+0.3%avg vs market, 10d
4.6%avg move, T+1

By company

25 companies · open one for its every result
CompanyJudgedRightWrongFlatHit rateAvg vs mkt
ASTERDM Aster DM Quality Care Ltd. 25 2 1 2 67% +2.6% ›
ERIS Eris Lifesciences Ltd. 25 2 1 3 67% -0.4% ›
LALPATHLAB Dr. Lal Path Labs Ltd. 25 2 2 2 50% +0.4% ›
NEULANDLAB Neuland Laboratories Ltd. 25 0 2 3 0% -0.3% ›
SYNGENE Syngene International Ltd. 25 1 1 4 50% -2.3% ›
NATCOPHARM NATCO Pharma Ltd. 24 0 4 1 0% -0.8% ›
POLYMED Poly Medicure Ltd. 24 1 2 2 33% -2.5% ›
CAPLIPOINT Caplin Point Laboratories Ltd. 23 1 0 4 100% -0.1% ›
GLAXO Glaxosmithkline Pharmaceuticals Ltd. 23 2 0 2 100% +2.5% ›
GRANULES Granules India Ltd. 23 1 2 3 33% -0.5% ›
NH Narayana Hrudayalaya Ltd. 23 1 2 3 33% +2.0% ›
PFIZER Pfizer Ltd. 23 1 3 2 25% +1.8% ›
JUBLPHARMA Jubilant Pharmova Ltd. 22 0 3 2 0% +1.0% ›
KIMS Krishna Institute of Medical Sciences Ltd. 22 0 2 3 0% +2.0% ›
VIJAYA Vijaya Diagnostic Centre Ltd. 19 1 3 1 25% +0.1% ›
RAINBOW Rainbow Childrens Medicare Ltd. 17 0 3 3 0% -0.4% ›
MEDANTA Global Health Ltd. 15 1 1 4 50% +1.5% ›
CONCORDBIO Concord Biotech Ltd. 13 1 2 2 33% +2.9% ›
BLUEJET Blue Jet Healthcare Ltd. 12 1 0 2 100% +3.4% ›
EMCURE Emcure Pharmaceuticals Ltd. 9 0 0 0 — -0.6% ›
INDGN Indegene Ltd. 9 0 0 1 — +0.8% ›
ONESOURCE Onesource Specialty Pharma Ltd. 7 0 0 0 — -9.2% ›
ACUTAAS Acutaas Chemicals Ltd. 5 0 0 0 — +7.3% ›
ANTHEM Anthem Biosciences Ltd. 5 0 0 0 — +0.6% ›
COHANCE Cohance Lifesciences Ltd. 5 0 0 0 — -7.6% ›

Each result

Company ResultReadOutcomeT+1T+10vs marketRun-upResultWhy
NATCOPHARMNATCO Pharma Ltd. 14 Aug Q1FY27 — unread -0.5% -6.8% -5.7% -3% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • No read was made before this result; recorded for the base rate.
 ›
CAPLIPOINTCaplin Point Laboratories Ltd. 12 Aug Q1FY27 — unread +0.3% +2.8% +4.2% -4% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 7 points in the fortnight before — someone was taking stock home.
  • 1 more
 ›
JUBLPHARMAJubilant Pharmova Ltd. 7 Aug Q1FY27 — unread +3.5% -3.1% -1.7% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 11 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
POLYMEDPoly Medicure Ltd. 7 Aug Q1FY27 — unread +10.0% +2.6% +4.0% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 9 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
EMCUREEmcure Pharmaceuticals Ltd. 6 Aug Q1FY27 — unread +3.0% -3.8% -2.2% +3% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
VIJAYAVijaya Diagnostic Centre Ltd. 6 Aug Q1FY27 — unread +1.7% +9.8% +11.4% +0% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 8 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
ASTERDMAster DM Quality Care Ltd. 5 Aug Q1FY27 — unread +3.3% -9.1% -7.5% +9% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 3 more
 ›
COHANCECohance Lifesciences Ltd. 5 Aug Q1FY27 — unread +3.8% +10.7% +12.3% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 11 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
NEULANDLABNeuland Laboratories Ltd. 5 Aug Q1FY27 — unread +14.5% +18.1% +19.7% +10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
BLUEJETBlue Jet Healthcare Ltd. 3 Aug Q1FY27 — unread +0.3% +3.0% +5.5% +13% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 10 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
GLAXOGlaxosmithkline Pharmaceuticals Ltd. 3 Aug Q1FY27 — unread -3.5% +8.1% +10.6% +13% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 9 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
KIMSKrishna Institute of Medical Sciences Ltd. 3 Aug Q1FY27 — unread -2.2% -1.8% +0.7% +2% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 10 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
CONCORDBIOConcord Biotech Ltd. 31 Jul Q1FY27 unfavourable wrong -0.1% +6.6% +7.0% +8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 5 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
NHNarayana Hrudayalaya Ltd. 31 Jul Q1FY27 neutral neutral -5.4% -9.9% -9.5% +8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 1 more
 ›
INDGNIndegene Ltd. 30 Jul Q1FY27 neutral neutral +5.9% +8.0% +7.8% -1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 7 sector peers reported the same week; the sector read may already have been set.
 ›
MEDANTAGlobal Health Ltd. 30 Jul Q1FY27 strong neutral +2.0% +0.4% +0.2% +13% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
RAINBOWRainbow Childrens Medicare Ltd. 30 Jul Q1FY27 favourable wrong +1.6% -3.9% -4.1% +5% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 7 sector peers reported the same week; the sector read may already have been set.
 ›
ERISEris Lifesciences Ltd. 29 Jul Q1FY27 unfavourable right -5.0% -3.2% -3.8% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 1.6x its prior month in the fortnight before.
  • 1 more
 ›
SYNGENESyngene International Ltd. 29 Jul Q1FY27 unfavourable right -6.8% -3.1% -3.7% -8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 11 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
PFIZERPfizer Ltd. 28 Jul Q1FY27 unfavourable wrong +1.9% +6.5% +4.6% +5% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 7 sector peers reported the same week; the sector read may already have been set.
 ›
ACUTAASAcutaas Chemicals Ltd. 24 Jul Q1FY27 — unread +1.2% +0.7% -2.7% +4% no figures
  • The market itself moved +3.4% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
LALPATHLABDr. Lal Path Labs Ltd. 24 Jul Q1FY27 favourable right +2.6% +11.1% +7.6% +10% no figures
  • The market itself moved +3.4% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
ONESOURCEOnesource Specialty Pharma Ltd. 24 Jul Q1FY27 — unread +4.7% -4.7% -8.2% +3% no figures
  • The market itself moved +3.4% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
ANTHEMAnthem Biosciences Ltd. 21 Jul Q1FY27 — unread -1.7% +4.3% +2.5% +2% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 6 points in the fortnight before — someone was taking stock home.
  • 3 more
 ›
GRANULESGranules India Ltd. 21 Jul Q1FY27 strong wrong -2.6% -3.5% -5.3% +14% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its reversal habit held this quarter.
  • 1 more
 ›
CONCORDBIOConcord Biotech Ltd. 29 May Q4FY26 unfavourable wrong +10.9% +31.3% +30.0% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 1 more
 ›
NATCOPHARMNATCO Pharma Ltd. 29 May Q4FY26 strong wrong -7.5% -16.6% -17.9% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
BLUEJETBlue Jet Healthcare Ltd. 25 May Q4FY26 neutral neutral -2.3% -2.8% +0.5% +30% no figures
  • Ran up 30% in the 30 sessions before the result — a good number had little left to reward.
  • The market itself moved -3.3% over the same ten sessions; the raw move is mostly tide.
  • 3 more
 ›
POLYMEDPoly Medicure Ltd. 25 May Q4FY26 neutral neutral -14.0% -5.7% -2.4% +8% no figures
  • The market itself moved -3.3% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 1 more
 ›
RAINBOWRainbow Childrens Medicare Ltd. 23 May Q4FY26 neutral neutral +0.8% -0.9% +1.6% +7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 sector peers reported the same week; the sector read may already have been set.
 ›
JUBLPHARMAJubilant Pharmova Ltd. 22 May Q4FY26 favourable wrong -2.1% -4.9% -2.4% +15% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
NHNarayana Hrudayalaya Ltd. 22 May Q4FY26 unfavourable wrong +1.9% +3.5% +6.1% +8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
ERISEris Lifesciences Ltd. 20 May Q4FY26 weak right -7.8% -6.2% -5.2% +10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 1.9x its prior month in the fortnight before.
  • 1 more
 ›
ANTHEMAnthem Biosciences Ltd. 19 May Q4FY26 — unread -2.3% -4.7% -3.8% +19% no figures
  • Ran up 19% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
KIMSKrishna Institute of Medical Sciences Ltd. 15 May Q4FY26 neutral neutral -2.7% -1.0% +0.1% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 2.1x its prior month in the fortnight before.
  • 1 more
 ›
CAPLIPOINTCaplin Point Laboratories Ltd. 14 May Q4FY26 neutral neutral -1.9% +0.0% +0.6% +34% no figures
  • Ran up 34% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 more
 ›
MEDANTAGlobal Health Ltd. 14 May Q4FY26 favourable neutral +2.3% -1.9% -1.3% +26% no figures
  • Ran up 26% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 more
 ›
COHANCECohance Lifesciences Ltd. 12 May Q4FY26 — unread -8.1% -11.5% -13.8% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 2.4x its prior month in the fortnight before.
  • 2 more
 ›
NEULANDLABNeuland Laboratories Ltd. 12 May Q4FY26 strong wrong -1.9% -1.4% -3.6% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 2.0x its prior month in the fortnight before.
  • 1 more
 ›
PFIZERPfizer Ltd. 12 May Q4FY26 weak right -0.9% -2.2% -4.4% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 7 sector peers reported the same week; the sector read may already have been set.
 ›
VIJAYAVijaya Diagnostic Centre Ltd. 7 May Q4FY26 strong right +11.1% +1.6% +4.1% +37% no figures
  • Ran up 37% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 more
 ›
EMCUREEmcure Pharmaceuticals Ltd. 5 May Q4FY26 — unread -1.5% +2.6% +4.1% +15% no figures
  • Its sector moved +5.0% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
ACUTAASAcutaas Chemicals Ltd. 30 Apr Q4FY26 — unread +2.4% +7.9% +9.4% +13% no figures
  • Its sector moved +5.8% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 more
 ›
ASTERDMAster DM Quality Care Ltd. 30 Apr Q4FY26 favourable right +6.0% +7.7% +9.2% +5% no figures
  • Its sector moved +5.8% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 more
 ›
LALPATHLABDr. Lal Path Labs Ltd. 30 Apr Q4FY26 unfavourable wrong +12.4% +20.4% +21.9% +3% no figures
  • Its sector moved +5.8% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
GRANULESGranules India Ltd. 29 Apr Q4FY26 favourable right -0.2% +4.5% +6.7% +24% no figures
  • Ran up 24% in the 30 sessions before the result — a good number had little left to reward.
  • Its sector moved +5.4% over the window.
  • 5 more
 ›
INDGNIndegene Ltd. 29 Apr Q4FY26 — unread +7.6% +4.2% +6.4% +14% no figures
  • Its sector moved +5.4% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
SYNGENESyngene International Ltd. 29 Apr Q4FY26 unfavourable wrong +10.5% +5.1% +7.3% +5% no figures
  • Its sector moved +5.4% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
BLUEJETBlue Jet Healthcare Ltd. 13 Feb Q3FY26 weak neutral -8.9% -3.2% -0.8% -25% no figures
  • Fell 25% in the 30 sessions before the result — expectations were already low.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 more
 ›
ERISEris Lifesciences Ltd. 13 Feb Q3FY26 unfavourable neutral -5.7% -3.8% -1.4% -6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual reversal pattern did not hold this quarter.
  • 1 more
 ›
NHNarayana Hrudayalaya Ltd. 13 Feb Q3FY26 unfavourable neutral +0.5% -1.8% +0.6% -6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 9 sector peers reported the same week; the sector read may already have been set.
 ›
VIJAYAVijaya Diagnostic Centre Ltd. 13 Feb Q3FY26 neutral neutral +3.5% -0.9% +1.5% -5% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual continuation pattern did not hold this quarter.
  • 1 more
 ›
COHANCECohance Lifesciences Ltd. 12 Feb Q3FY26 — unread -12.6% -11.6% -9.2% -34% no figures
  • Fell 34% in the 30 sessions before the result — expectations were already low.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 more
 ›
NATCOPHARMNATCO Pharma Ltd. 12 Feb Q3FY26 unfavourable wrong +5.0% +17.7% +20.1% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual continuation pattern did not hold this quarter.
  • 1 more
 ›
CONCORDBIOConcord Biotech Ltd. 11 Feb Q3FY26 neutral neutral -4.9% +0.5% +2.3% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 5.9x its prior month in the fortnight before.
  • 2 more
 ›
GLAXOGlaxosmithkline Pharmaceuticals Ltd. 9 Feb Q3FY26 neutral neutral +7.3% +4.1% +5.8% +2% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 9 sector peers reported the same week; the sector read may already have been set.
 ›
NEULANDLABNeuland Laboratories Ltd. 9 Feb Q3FY26 neutral neutral -5.0% -3.8% -2.1% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 9 sector peers reported the same week; the sector read may already have been set.
 ›
PFIZERPfizer Ltd. 9 Feb Q3FY26 unfavourable wrong +9.1% +6.7% +8.4% -6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual continuation pattern did not hold this quarter.
  • 1 more
 ›
JUBLPHARMAJubilant Pharmova Ltd. 6 Feb Q3FY26 neutral neutral -0.1% -3.9% -4.0% -12% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual reversal pattern did not hold this quarter.
  • 1 more
 ›
KIMSKrishna Institute of Medical Sciences Ltd. 6 Feb Q3FY26 unfavourable wrong +9.2% +20.5% +20.5% -6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its reversal habit held this quarter.
  • 1 more
 ›
Page 1 of 8 · 448 results Older →